IHM
XBI icon

Iguana Healthcare Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Iguana Healthcare Management’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-75,000
Closed -$4.66M – 77
2014
Q4 		$4.66M Buy
+75,000
New +$4.28M 2.25% 12

Other funds holding XBI

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

Iguana Healthcare Management's XBI Position: Q1 2017 in Review

Iguana Healthcare Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2017, closing a stake of 10,000 shares — an estimated $592K sold.

Iguana Healthcare Management first reported a position in XBI in Q4 2016 and held it in 1 quarter. The position peaked at $592K in Q4 2016. 292 funds tracked by Wall St. Rank hold XBI as of Q1 2017.

  • Iguana Healthcare Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2017 after selling out during the quarter.
  • Iguana Healthcare Management sold 10,000 State Street SPDR S&P Biotech ETF shares in Q1 2017, an estimated $592K.
  • Iguana Healthcare Management first reported a position in State Street SPDR S&P Biotech ETF in Q4 2016 and held it in 1 quarter.
  • Iguana Healthcare Management's State Street SPDR S&P Biotech ETF position peaked at $592K in Q4 2016.
  • 292 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2017.

Based on Iguana Healthcare Management's 13F filing for Q1 2017, filed 15 May 2017.